Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |